Table 2. Best response to EGFR TKI therapy.
Response rate (RR) | First-line TKI therapy (n = 233) | Second-line TKI therapy (n = 169) |
---|---|---|
Complete response (CR), n (%) | 11 (4.7%) | 2 (1.2%) |
Partial response (PR), n (%) | 147 (63.1%) | 92 (54.4%) |
Stable disease (SD), n (%) | 58 (24.9%) | 55 (30.8%) |
Progressive disease (PD), n (%) | 17 (7.3%) | 23 (13.6%) |
Objective response rate (ORR), n(%) | 158 (67.8%) | 94 (55.6%) |
Abbreviation: TKI, tyrosine kinase inhibitor.